Search

everythinglearnresearchcommunity

for

Search:↓

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Compound 1 showed promising anticancer activity.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Newly made nicotinamide compounds could potentially treat cancer.

The Rigenera method improved hair thickness and reduced hair loss in patients.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

New psoriasis treatments are effective but come with side effects and risks.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Geranium plants have healing properties like fighting microbes, protecting the liver, reducing inflammation, and may help with viruses, stomach issues, and diabetes.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

A new therapy for a skin blistering condition has not been developed yet.

Certain Dibenzo derivatives may help treat prostate cancer.

Recombinant Filaggrin-2 microneedles effectively promote hair growth and repair in hair loss.

Microemulsions improve adapalene's skin absorption for better acne treatment.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

AH-001 could be a safer and more effective treatment for hair loss.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.